The Global Market for Biotechnology Instrumentation is Projected to Reach US$52.4 Billion by 2022
Expanding Biotech Research & Exploration of New
Drugs to Drive the Biotechnology Instrumentation Market, According to a New
Report by Global Industry Analysts, Inc.
GIA launches comprehensive
analysis of industry segments, trends, growth drivers, market share, size and
demand forecasts on the global Biotechnology Instrumentation market. The global market for Biotechnology Instrumentation is
projected to reach US$52.4 billion by 2022, driven by the exploration for new drugs, enhancements in performance
of prevailing technology platforms, and conceptualization of new measurement
and instrument configuration systems.
Biotechnology has evolved
into a wide and diverse industry over the years having undergone a transition
from mere application of cultured microorganisms and animal and plant breeding
processes to an advanced industry involving the use of various scientific and
engineering disciplines. Today, biotechnology has become an important part of
virtually every sector of the economy including chemical, agrochemical,
beverage, food processing, healthcare, forensics, agriculture environmental
monitoring, and animal husbandry, among others. The pharmaceuticals industry is
the principal force driving the biotechnology revolution, primarily due to constant
exploration for new drugs. Biotechnology instruments and tools are used in
universities and pharmaceutical company research labs for cellular and
molecular examination. Analytical instruments such as centrifuges, DNA synthesizers, protein analyzers and bio robotics are used by research laboratories
in universities, and biotechnology and pharmaceutical companies. Over the years
use of bioinstrumentation techniques has become simple and more accessible.
Demand for faster and
economical ways to produce drugs for the pharmaceutical industry, proteomics,
genomics, functional genomics and combinatorial chemistry have led to the
advancements of bioinstrumentation in recent years. In addition to the human
genome project that created ripples in the areas of proteomics and genomics,
the market is also driven by considerable enhancements in performance of
prevailing technology platforms, and conceptualization of new measurement and
instrument configuration systems. Continuous advancements promise growth
opportunities in clinical diagnostics, life sciences research, and personalized
medicine. The evolution of Next-Generation Sequencing (NGS) technology has
resulted in development of advanced molecular tools to facilitate the profiling
the transcriptome and aid in the detection and analysis of noncoding RNA to
understand cancer biology and create new therapeutic targets for cancer. The
industry is expected to gain from expanding research and breakthroughs in areas
such as molecular biology, next generation sequencing, and bioinformatics to analyze and
interpret information at molecular level.
As stated by the new
market research report on Biotechnology Instrumentation, the United States represents the largest market
worldwide. Asia-Pacific is forecast to record the fastest CAGR of 9.5% over the
analysis period led by robust growth from the Chinese and Indian markets.
Growing population, rising per capita income, increasing government spending and
increasing focus on research and development activity are the major factors
contributing to the growth in the region.
Major players covered in
the report include Agilent Technologies Inc., Beckman Coulter Inc., Bio-Rad
Laboratories Inc., C.B.S Scientific Company Inc., GE HealthCare (UK), Gilson
Inc., Harvard Bioscience Inc., Hitachi High-Technologies Corp., Illumina Inc.,
Lonza Group AG, PerkinElmer Inc., Shimadzu Corp., and Thermo Fisher Scientific
Inc., among others.
The research report titled
“Biotechnology Instrumentation: A Global Strategic
Business Report” announced by Global
Industry Analysts Inc., provides a comprehensive
review of market trends, issues, drivers, mergers, acquisitions and other
strategic industry activities of global companies. The report provides market
estimates and projections in value terms for all major geographic markets such
as the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain, Russia and
Rest of Europe), Asia-Pacific (China, India and Rest of Asia-Pacific), Latin
America (Brazil, Mexico and Rest of Latin America) and Rest of World. Product
segments analyzed include DNA Sequencing Systems, DNA Synthesizers, Electrophoresis
Systems, Immunoassay Systems, Laboratory Automation, Liquid Chromatography
Systems, Mass Spectrometry, MicroArrays, and Protein/Peptide Synthesizers.
Global
Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights
Reserved.
Comments
Post a Comment